A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary FibrosisKING, Talmadge E; BRADFORD, Williamson Z; LEDERER, David J et al.The New England journal of medicine. 2014, Vol 370, Num 22, pp 2083-2092, issn 0028-4793, 10 p.Article

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trialKING, Talmadge E; ALBERA, Carlo; VALEYRE, Dominique et al.Lancet (British edition). 2009, Vol 374, Num 9685, pp 222-228, issn 0140-6736, 7 p.Article

Ascertainment of Individual Risk of Mortality for Patients with Idiopathic Pulmonary FibrosisDU BOIS, Roland M; WEYCKER, Derek; SZWARCBERG, Javier et al.American journal of respiratory and critical care medicine. 2011, Vol 184, Num 4, pp 459-466, issn 1073-449X, 8 p.Article

BUILD-1 : A Randomized Placebo-controlled Trial of Bosentan in Idiopathic Pulmonary FibrosisKING, Talmadge E; BEHR, Jürgen; BROWN, Kevin K et al.American journal of respiratory and critical care medicine. 2008, Vol 177, Num 1, pp 75-81, issn 1073-449X, 7 p.Article

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trialsNOBLE, Paul W; ALBERA, Carlo; VALEYRE, Dominique et al.Lancet (British edition). 2011, Vol 377, Num 9779, pp 1760-1769, issn 0140-6736, 10 p.Article

Forced Vital Capacity in Patients with Idiopathic Pulmonary Fibrosis: Test Properties and Minimal Clinically Important DifferenceDU BOIS, Roland M; WEYCKER, Derek; THOMEER, Michiel et al.American journal of respiratory and critical care medicine. 2011, Vol 184, Num 12, pp 1382-1389, issn 1073-449X, 8 p.Article

Current diagnosis and management of idiopathic pulmonary fibrosis : A survey of academic physiciansCOLLARD, Harold R; LOYD, James E; KING, Talmadge E et al.Respiratory medicine. 2007, Vol 101, Num 9, pp 2011-2016, issn 0954-6111, 6 p.Article

Obstructive Sleep Apnea Is Common in Idiopathic Pulmonary FibrosisLANCASTER, Lisa H; MASON, Wendi R; PARNELL, James A et al.Chest (American College of Chest Physicians). 2009, Vol 136, Num 3, pp 772-778, issn 0012-3692, 7 p.Article

Serum Inter-α-Trypsin Inhibitor and Matrix Hyaluronan Promote Angiogenesis in Fibrotic Lung InjuryGARANTZIOTIS, Stavros; ZUDAIRE, Enrique; NOBLE, Paul W et al.American journal of respiratory and critical care medicine. 2008, Vol 178, Num 9, pp 939-947, issn 1073-449X, 9 p.Article

Multiorgan nuclear factor kappa B activation in a transgenic mouse model of systemic inflammationBLACKWELL, Timothy S; YULL, Fiona E; CHEN, Chih-Li et al.American journal of respiratory and critical care medicine. 2000, Vol 162, Num 3, pp 1095-1101, issn 1073-449X, 1Article

Viral Infection in Acute Exacerbation of Idiopathic Pulmonary FibrosisCHAO WOOTTON, Sharon; DONG SOON KIM; LANCASTER, Lisa H et al.American journal of respiratory and critical care medicine. 2011, Vol 183, Num 12, pp 1698-1702, issn 1073-449X, 5 p.Article